ARCA biopharma(ABIO) - 2024 Q2 - Quarterly Results

Exhibit 99.1 ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update ------------------------------------------------------------------------------------------------------------ Westminster, CO, August 1, 2024 – ARCA biopharma, Inc. (Nasdaq: ABIO), (the "Company") a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2024 financial results and provided a c ...